344 related articles for article (PubMed ID: 25690018)
1. Pharmacogenetics and breast cancer management: current status and perspectives.
Ciccolini J; Fanciullino R; Serdjebi C; Milano G
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside analogs: ready to enter the era of precision medicine?
Ciccolini J; Serdjebi C; Le Thi Thu H; Lacarelle B; Milano G; Fanciullino R
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):865-77. PubMed ID: 27218825
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic Predictors of Response.
Hertz DL; Rae JM
Adv Exp Med Biol; 2016; 882():191-215. PubMed ID: 26987536
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine in oncology: where have we come from and where are we going?
André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Marsh S; Liu G
Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman RA
Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
[TBL] [Abstract][Full Text] [Related]
10. Impact of variants in ATP-binding cassette transporters on breast cancer treatment.
Xiao Q; Zhou Y; Lauschke VM
Pharmacogenomics; 2020 Dec; 21(18):1299-1310. PubMed ID: 33222659
[TBL] [Abstract][Full Text] [Related]
11. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
Shai RM; Reichardt JK; Chen TC
Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.
Longo R; D'Andrea M; Sarmiento R; Gasparini G
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S41-50. PubMed ID: 20374029
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics in breast cancer: current trends and future directions.
Wajapeyee N; Somasundaram K
Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics and breast cancer.
Lymberis SC; Parhar PK; Katsoulakis E; Formenti SC
Pharmacogenomics; 2004 Jan; 5(1):31-55. PubMed ID: 14683419
[TBL] [Abstract][Full Text] [Related]
16. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.
Iyer PM; Karthikeyan S; Sanjay Kumar P; Krishnan Namboori PK
Funct Integr Genomics; 2017 Jul; 17(4):375-385. PubMed ID: 28470340
[TBL] [Abstract][Full Text] [Related]
19. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
20. Advances and challenges in hereditary cancer pharmacogenetics.
Cascorbi I; Werk AN
Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]